← SynDRA
FLOCTAFENINE
SynDRA canonical compound SYN0031027 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | PTGS1 | PTGS2 |
|---|
| Mechanism of action | cyclooxygenase inhibitor |
|---|
| Indication | pain relief |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- cyclooxygenase inhibitor
- PTGS2 INHIBITOR
- PTGS1 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP1A2
- CP2C9
- CP2CJ
- CP2D6
- CP3A4
- CP3A7
- ESR2
- ESRRA
- GLI3
- NF2L2
- NR1I2
- PPARG
- PRGR
Drug classes
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Antirheumatic Agents
- Peripheral Nervous System Agents
- Sensory System Agents
ATC classes
- N02B · OTHER ANALGESICS AND ANTIPYRETICS
Cross-references
Synonyms
- idarac
- diralgan
- floctafenin
- novodolan
- Floctafenina
- Diralgan
- Floctafenin
- Idalon
- Novodolan
- R-4318
- R-4138
- RU-15750
- Idarac
- 2,3-Dihydroxypropyl 2-((8-(trifluoromethyl)quinolin-4-yl)amino)benzoate
- RU 15750
- R 4318
- Floctafeninum [INN-Latin]
- Floctafenina [INN-Spanish]
- 8-Trifluoromethyl-7-deschloroglafenine
- C20H17F3N2O4
- EINECS 245-881-4
- BRN 0457808
- 2,3-Dihydroxypropyl 2-((8-(trifluoromethyl)-quinolin-4-yl)amino)benzoate
- 2,3-Dihydroxypropyl N-(8-(trifluoromethyl)-4-quinolyl)anthranilate
- 4-(o-(2',3'-Dihydroxypropyloxycarbonyl)phenyl)-amino-8-trifluoromethylquinoline
- FLOCTAFENIN
- Ru-15750
- Floctafeninum
- O04HVX6A9Q
- DTXCID9031484
- RefChem:599296
- N02BG04
- Duralgin
- UNII-O04HVX6A9Q
- Floctafenine [USAN:INN:BAN:JAN]
- Idarac (TN)
- FLOCTAFENINE [MI]
- FLOCTAFENINE [INN]
Look up FLOCTAFENINE in the interactive SynDRA portal →